Dr. Kristianne Hannemann, PharmD
Dr. Kristianne Hannemann is a licensed pharmacist with over seven years of experience in community pharmacy and patient education. She specializes in medical writing and drug information. Dr. Hannemann is passionate about delivering current, evidence-based medication information in a clear, accessible format, empowering patients to confidently navigate their health journey.
Recent Review Blogs
Trulicity vs Mounjaro: 5% vs 21% Weight Loss – Complete Comparison
Mounjaro crushes Trulicity for weight loss: clinical trials demonstrate 21% body weight reduction versus just 5% with Trulicity. Both are FDA-approved diabetes medications, but they work through different mechanisms Mounjaro activates dual GLP-1/GIP receptors while Trulicity targets only GLP-1. The landmark SURPASS-CVOT head-to-head trial confirmed Mounjaro delivers superior A1c reduction and cardiovascular outcomes compared to [...]
Contrave vs Wegovy: Which Weight Loss Medication Is Right for You?
Wegovy obliterates Contrave in raw weight loss numbers: 15% body weight reduction versus 5-8%, GLP-1 injection versus naltrexone/bupropion pills. But choosing a weight loss medication is never just about the scale. Contrave targets the brain’s reward system to reduce food cravings and emotional eating, while Wegovy mimics the gut hormone GLP-1 to suppress appetite and [...]
Trulicity Side Effects: Complete Guide with Clinical Data & Management Timeline
According to clinical trial data, gastrointestinal side effects are the most frequently reported adverse reactions with Trulicity (1.5 mg). Nausea affects up to 21.1% of patients, while diarrhea, vomiting, and abdominal pain each occur in 9-13% of users. These side effects of Trulicity are typically mild to moderate and tend to decrease over time as [...]
Rybelsus Dosage: 3mg→7mg→14mg Titration Schedule + Weight Loss Guide
According to the FDA prescribing information, Rybelsus treatment begins with a 3mg starting dose taken once daily for 30 days. This initial dosage is intended for treatment initiation and is not meant for long-term blood sugar control. It primarily helps your body adapt to the medication and reduces gastrointestinal side effects. After the first month, [...]
Victoza vs Saxenda: Same Drug, Different Doses – Diabetes vs Weight Loss Pens
Victoza and Saxenda are both brand-name drugs manufactured by Novo Nordisk that contain the same active ingredient: liraglutide. Despite sharing an identical GLP-1 molecule, these two medications have different FDA approvals and maximum dosing. Victoza (liraglutide 0.6-1.8mg daily) is approved for managing blood sugar levels in adults with type 2 diabetes, while Saxenda (liraglutide 3.0mg [...]
Saxenda Dosage Guide: 0.6mg Start to 3mg Max (5-Week Titration Schedule)
Saxenda dosing starts at 0.6 mg once daily and is gradually increased by 0.6 mg every week until reaching the maintenance dose of 3.0 mg daily-this FDA-approved titration schedule takes approximately 5 weeks to complete. The active ingredient in Saxenda is liraglutide, a GLP-1 receptor agonist manufactured by Novo Nordisk for chronic weight management in [...]
Trulicity vs Zepbound: 4-7% vs 21% Loss – Dual GIP/GLP-1 vs GLP-1
Zepbound delivers dramatically superior weight loss results: participants in clinical trials lost an average of 21% body weight (approximately 48 lbs at the highest dose) compared to Trulicity's modest 4-7% weight loss (7-10 lbs). This substantial difference stems from their fundamentally different mechanisms-Zepbound is a dual GIP and GLP-1 receptor agonist, while Trulicity operates solely [...]
Contrave vs Zepbound 2026: 22.5% vs 8.1% Weight Loss – Pill vs Dual Hormone Injection
Zepbound (tirzepatide) produces approximately 22.5% average total body weight loss at the maximum 15 mg dose over 72 weeks, according to the SURMOUNT-1 clinical trial published in the New England Journal of Medicine. Contrave (naltrexone/bupropion) shows an average of 8.1% total body weight loss at the maximum daily dose over 56 weeks, as documented in [...]
How Zepbound Works: Dual GLP-1/GIP Action – Appetite Off Week 1
Zepbound activates GLP-1 and GIP receptors simultaneously-reducing appetite significantly within days, slowing gastric emptying by approximately 40%, and producing average weight loss of up to 21% by week 72. This dual hormone action is superior to single GLP-1 drugs like Wegovy and Ozempic. According to the FDA approval announcement, Zepbound (tirzepatide) represents a breakthrough in [...]
Zepbound Dose Schedule: 2.5mg Start → 15mg Max + Maintenance Guide
The Zepbound dose schedule follows FDA-approved titration starting at 2.5mg once weekly, increasing every 4 weeks to reach the maximum recommended dosage of 15mg. According to FDA prescribing information, this slow titration approach reduces gastrointestinal adverse reactions while allowing your body to adjust to this injectable prescription medicine. In clinical trials like SURMOUNT-1, adults taking [...]
Zepbound Injection Sites: Abdomen, Thigh, Arm + Needle Size Guide
The Zepbound auto-injector delivers precise doses ranging from 2.5mg to 15mg in approximately 10 seconds. According to the FDA prescribing information, the approved injection sites for Zepbound are the stomach (maintaining at least 2 inches from the navel), outer thigh, and back of the upper arm. The Zepbound pen comes with a pre-attached 32-gauge, 4mm [...]
Zepbound Side Effects: Nausea, GI Symptoms & Muscle Pain Timeline Guide
Zepbound side effects impact approximately 82% of users during the first month of treatment, with nausea (up to 29%), diarrhea (up to 23%), constipation (up to 17%), and vomiting (up to 13%) being the most frequently reported according to FDA prescribing information. These gastrointestinal symptoms typically peak during weeks 4-8 when patients are titrating to [...]
Mounjaro Nausea: 12-24% Rate Peaks Week 4 – 90% Resolve Management Guide
Mounjaro (tirzepatide) is an FDA-approved medication that helps manage blood glucose levels in adults with Type 2 diabetes and is also highly effective for weight loss. While this weight loss injection has shown remarkable results in clinical trials, helping people lose weight significantly, nausea from Mounjaro remains the most common side effect that patients experience [...]
Mounjaro Face: Facial Fat Loss from Rapid Weight Loss – Prevention Guide
Mounjaro face describes the gaunt, hollow facial appearance that develops when tirzepatide therapy causes rapid facial fat loss. This phenomenon affects approximately 15-25% of women over 40 using weight loss medications and results from the body losing subcutaneous fat from the cheeks, temples, and under-eye areas faster than the skin can adapt. According to the [...]
Does Mounjaro Make You Tired? 8-12% Fatigue Rate + Evidence-Based Recovery
Mounjaro (tirzepatide) is an FDA-approved medication to treat type 2 diabetes and support weight loss by mimicking two naturally occurring hormones: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1. These hormones work by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and managing blood sugar levels. While taking Mounjaro, many patients report feeling tired-particularly during the initial [...]
Zepbound vs Wegovy: 20% vs 14% Weight Loss – Head-to-Head Trial
Zepbound beats Wegovy with 20.2% vs 13.7% body weight loss in the first-ever head-to-head trial (SURMOUNT-5), published in the New England Journal of Medicine. The key difference: Zepbound is a dual GLP-1 and GIP receptor agonist, while Wegovy targets only GLP-1. Both are FDA-approved injectable weight loss medications that require weekly injections alongside healthy eating [...]
How Much Weight Can You Lose on Wegovy? 15-17% Average + Timeline Chart
The average weight loss on Wegovy is 15% of body weight (approximately 35 pounds) after 68 weeks of treatment with the 2.4mg maintenance dose, according to clinical trial data published in the New England Journal of Medicine. This once-weekly injection, containing the active ingredient semaglutide, works by mimicking a natural hormone called GLP-1 that signals [...]
Wegovy for PCOS: 15% Weight Loss + Insulin Sensitivity Benefits
Wegovy for PCOS is gaining attention as a potential treatment option for women struggling with polycystic ovary syndrome and weight-related symptoms. Between 38% to 88% of women with PCOS are overweight or obese, making weight loss a primary treatment goal. Research shows that losing even 5-10% of body weight can improve many aspects of PCOS, [...]
Wegovy vs Mounjaro: Mounjaro (20%) Weight Loss vs Wegovy (14%) Complete Comparison
In the groundbreaking SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine, Mounjaro achieved 20.2% average weight loss compared to Wegovy's 13.7% over 72 weeks. The key difference lies in their mechanisms: Wegovy (semaglutide) is a GLP 1 receptor agonist that mimics a naturally occurring hormone to reduce appetite and control blood sugar. [...]
How to Use Wegovy Pen: Step-by-Step Instructions & Troubleshooting
The Wegovy pen is designed to be simple and user friendly for self administered injections. As a once weekly injection for weight management, Wegovy (semaglutide) comes in a pre filled, single dose pen that requires no manual dose selection. Each pen contains one exact preset dose making it nearly impossible to administer the wrong amount [...]
